Business Wire - ILEX Oncology In-Licenses Novel, Orally Active Anti-Cancer Comp
Posted on Wednesday, September 06 @ 07:00:00 CDT by admin
September 6, 2000 -- Business Editors & Health/Medical Writers SAN ANTONIO--(BUSINESS WIRE)--Sept. 6, 2000 ILEX(tm) Oncology Inc. (Nasdaq:ILXO) announced that it has ...
Click Here to read the entire article...
|
| |
|